Global Infusion Systems Market is segmented By Product (Elastomeric infusion system, Volumetric infusion system, Patient Controlled Analgesia pump, Disposable infusion system, Syringe infusion system, Ambulatory infusion system, Implantable infusion system), By Application (Chemotherapy, Diabetes, Pain Management, Gastrointestinal Disorders, Clinical nutrition, Paediatrics), By End-User (Hospitals, Diagnostic Centres, Specialty Oncology wards, Homecare), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Report Overview
Global Infusion Systems market is estimated to grow at a CAGR of 5.9% during the forecast period 2024-2031.
Infusion Systems is a device used to deliver fluids into a patient’s body in a controlled manner. They may be used to provide nutrients or medications – such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers.
Market Summary
|
Metrics |
Details |
|
Market CAGR |
5.9% |
|
Segments Covered |
By Product, By Application, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
For more insights Request Free Sample
Market Dynamics
The infusion systems market growth is driven by several factors including, the rising prevalence of chronic diseases such as cancer and diabetes, significant technological advancements, and various new product launches.
Increasing prevalence of chronic diseases and rising technological advancements are expected to drive the growth of market.
The major drivers fueling the growth of the market are the high prevalence of cancer and chronic diseases such as diabetes, especially in geriatric patients and increasing technical advancements.
According to National Centre for Health, in 2022, cancer was the second leading cause of mortality worldwide, with around 1,918,030 new cases registered in 2022. Cancer was responsible for 609,360 deaths all over the world. Moreover, as per WHO the number of new cases is expected to rise by around 70% by 2030. The administration of chemotherapy drugs is efficient with the help of latest infusion systems, and there is a rise in the adoption of antimicrobial catheters by cancer patients globally.
Even chronic diseases require infusion systems, according to the study by the University of California, around 5 million people worldwide are affected by the end-stage renal disease (ESRD), and the number of patients diagnosed with the disease is expected to increase at a rate of 5-7% annually.
The rise in the launch of cost-effective and convenient elastomeric infusion pump products shall boost the market growth. For instance, in April 2021, B. Braun had launched Spaceplus that is a novel infusion pump combined with OnlineSuiteplus a kind of ecosystem that provides various benefits including connectivity, data management, cloud-based applications, excellent therapy and update flexibility.
Patient safety concern and improper infusion is expected to hamper the market growth.
The factors concerning patient safety and improper infusion leading to severe consequences will hamper the growth of the market. A study published in Dec 2019, titled “Risk of Medication Errors with Infusion Pumps” reported total 1,004 events related to use of infusion pump and medication error that occurred in 132 hospitals in Pennsylvania. 22% of these incidents were related to high-alert medication, majority of events were less harmful and didn’t lead to any serious harm or death.
Industry Analysis
The global infusion systems market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, regulatory analysis, supply chain analysis, and pricing analysis.
Market Segmentation Analysis
Elastomer infusion systems segment is expected to hold the largest market share in global infusion systems market
The global infusion systems market can be segmented by market by product type, by application, by end-user, and by region. Based on product type, the market is segmented into elastomeric infusion systems, volumetric infusion systems, patient-controlled analgesia pump, disposable infusion system, syringe infusion system, ambulatory infusion system, and implantable infusion system. The volumetric infusion system is sub-segmented into large volume and small volume pumps.
By end-user, the market is segmented into the hospital, diagnostic centers, specialty oncology wards, and home care settings. Infusion systems are extensively used in hospitals and home care settings to provide improved care to patients.
The elastomer infusion pump market is segmented into product types as continuous rate pumps and variable rate pumps. The continuous rate pumps account for the highest market share due to the high adoption of continuous rate elastomer infusion pumps to treat several diseases including cancer and chronic diseases as it provides efficient performance and stability. It is widely used for post-operative pain management. The market is dominated by the availability of several continuous rates of elastomer infusion pumps. For instance, Smiths Medical’s Neofuser is a single-use, portable elastomeric infusion pump that provides the medication at a continuous pre-fixed flow. It is used to infuse chemotherapy, antibiotic therapy, analgesic therapy, and other general intravenous, intraarterial, subcutaneous, epidural, perineural, and intralesional infusions. Smith Medical’s Neofuser Vario is a single-use, portable elastomeric multi-rate infusion pump used for systemic or regional preoperative and postoperative pain management therapy. It is available in different reservoir sizes to select 7 different flow rates and stop the flow with a detachable key.
The chemotherapy segment is expected to have a positive market share due to an elastomer infusion pump's rising uptake for delivering chemotherapy. The increasing incidence of cancer as the elastomer infusion pump effectively delivers chemotherapy directly into the bloodstream and reducing the risk of developing occlusion. There is an increase in the number of companies developing the elastomer infusion pump for chemotherapy infusion. Halyard Health, Baxter International Inc, Epic Medical, Nipro Medical Corporation are the major players for the elastomer infusion pump for chemotherapy infusion.
Market Geographical Share
North America region holds the largest market share in the global infusion systems market
As per the research study, the global market is divided into majorly five regions such as North America, South America, Europe, the Middle East, Africa, Asia Pacific, and the Rest of the world.
North America is the leading market for Infusion Systems and accounted for a major revenue share. According to the U.S. Department of Health and Human Services, national expenditures for cancer treatment in the U.S. were nearly US$ 125 billion in 2010 and US$ 156 billion by 2020. The reasons are improved medical facilities and greatly developed healthcare infrastructure and rising occurrence of cancer, cardiovascular, end-stage renal diseases, and the growing geriatric population.
Europe accounts for the second-largest market of Infusion Systems. The market is rising because of the increased occurrence of cases of cardiac and cancer-related diseases along with well-developed healthcare infrastructure including advanced machines and equipment. According to WHO, in 2020, about 37% of the population aged over 65 years in Europe had at least one chronic disorder, and 27% of the population from the same age group has two chronic disorders, and 29% of the population has three or more chronic disorders.
Asia Pacific is registering the fastest CAGR due to the increasing number of manufacturers and key market players in this region. Various novel technological advancements and latest product launches are taking place in countries such as India, China, and Japan. In Aug 2022, Terumo Corporation announced that G-Lasta subcutaneous injection got approved by Japan Ministry Health, Labour and Welfare. G-Lasta is a product with drug-device combination that is co-developed by Kyowa Kirin Co. This will minimise the febrile neutropenia incidence in patients undergoing chemotherapy.
Market Competitive Landscape
Some of the major key players in the global Infusion Systems market are Smiths Medical (ICU Medical), Terumo Medical Corporation, NIPRO Medical Corporation, Zyno Medical, Braun, Baxter International, Fresenius, Iradimed Corporation and Hospira.
The key companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally. For instance,
- In May 2022, Terumo Pharmaceutical announced the launche of Plajex a pre-fillable syringe for low dose medication application. Plajex is a syringe that is pre-fillable with luer lock silicone developed for low dose application. For application of high value drug like intravitreal injection it is very suitable option.
- For instance, in Nov 2020, Ambu Inc. announced their contract with Intalere that will work for pain care management solutions. Intlere is going to receive Ambu ACTion TM block pain pump.
- For instance, in February 2020, LTR Medical had entered into an exclusive distribution agreement with Woo Young Medical to distribute their new generation of elastomeric infusion technologies into the Australian market.
Global Infusion Systems Market – Key Companies to Watch
Smith’s Medical (ICU Medical Inc.):
Overview: Smith Medicals now a part of ICU Medical Inc. develops and markets innovative medical products in vascular access, infusion therapy and vital care applications. Its medical products include large volume IV pumps, syringe, needlefree IV connectors, sterile IV solutions, peripheral IV catheters, dedicated & non-dedicated IV sets and closed system transfer devices. It was founded in 1940 and is headquartered in California, United States.
Product Portfolio:
Graseby 2000 Syringe Pumps: The range of these Graseby 2000 syringe pumps delivers reliable and simple infusion for various areas of clinical therapy. These pumps provide continuous infusion of medicines with reasonable quality.
Key Developments: In Jan 2022, Smiths Medical got acquired by ICU Medical Inc from Smiths Group. Ambulatory infusion devices and vascular access are medical business of Smiths that on combining with ICU’s present business can make it a leading company in infusion therapy.
The global infusion systems market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
